Table 1.
Baseline characteristics of the cohort
| Standard care | Community weight loss groups | Total | |
|---|---|---|---|
| N | 28 | 45 | 73 |
| Female sex | 28 (100) | 42 (93.3) | 70 (95.9) |
| Ethnicity | |||
| White | 27 (96.4) | 42 (93.3) | 69 (94.5) |
| Black/mixed | 1 (3.6) | 3 (6.7) | 4 (5.5) |
| Type 2 diabetes | 1 (3.6) | 2 (4.4) | 3 (4.1) |
| Age, years | 55.19 (10.23) | 52.9 (13.46) | 53.78 (12.29) |
| Weight, kg | 82.02 (2.44) | 83.21 (2.64) | 82.75 (2.55) |
| BMI, kg/m2 | 31.25 (2.44) | 31 (2.64) | 31.1 (2.55) |
| Glucose, mmol/L* | 4.95 (0.83) | 4.8 (0.7) | 4.9 (0.8) |
| Insulin, pmol/L | 50.03 (27.37) | 53.62 (32.25) | 52.24 (30.32) |
| HbA1c, % | 5.66 (0.3) | 5.74 (0.44) | 5.71 (0.39) |
| HOMA2-IR | 5.88 (2.92) | 6.26 (3.4) | 6.12 (3.21) |
| Total cholesterol, mmol/L | 5.59 (1.06) | 5.56 (1.22) | 5.57 (1.15) |
| LDL cholesterol, mmol/L* | 3.65 (1.25) | 3.2 (1.5) | 3.3 (1.4) |
| HDL cholesterol, mmol/L | 1.4 (0.39) | 1.54 (0.44) | 1.48 (0.42) |
| Triglycerides, mmol/L* | 1.44 (0.85) | 1.2 (0.6) | 1.3 (0.8) |
| ELF score | 9.03 (0.78) | 8.88 (1.11) | 8.93 (0.99) |
| HA | 52.17 (44.36) | 51.97 (66.8) | 52.05 (58.86) |
| PIIINP | 8.8 (3.03) | 9.41 (4.51) | 9.17 (4) |
| TIMP1 | 210.32 (58.41) | 198.61 (53.55) | 203.1 (55.36) |
Data are presented as n (%) or mean (SD), unless otherwise indicated. * Data are presented as median (interquartile range). ELF, enhanced liver fibrosis; HA, hyaluronic acid; PIIINP, amino-terminal propeptide of type III procollagen; TIMP-1, tissue inhibitor of metalloproteinase 1.